Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: A pilot study in a rat model

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 4, 2010, Pages 1393-1402

  Baltes, Steffen ^a   Freund, Ina ^a   Lewis, Andrew L ^b   Nolte, Ingo ^c   Brinker, Thomas ^a  

^a INTERNATIONAL NEUROSCIENCE INSTITUTE   (Germany)

^b BIOCOMPATIBLES UK LTD   (United Kingdom)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOURS; DOXORUBICIN; EMBOLISATION; IRINOTECAN; LOCAL DELIVERY; MALIGNANT GLIOMA; PILOT STUDIES; RAT MODEL; SURVIVAL TIME; TISSUE DAMAGE;

DRUG DELIVERY;

TUMORS;

DOXORUBICIN; IRINOTECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN NECROSIS; BRAIN TISSUE; CHEMOEMBOLIZATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING BEAD; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK BENEFIT ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CAMPTOTHECIN; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; GLIOMA; INJECTIONS, INTRALESIONAL; MALE; MICROSPHERES; PILOT PROJECTS; RATS; SURVIVAL ANALYSIS;

RATTUS;

EID: 77951256371     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-009-3803-4     Document Type: Article

References (46)

1. A Chakravarti K Palanichamy 2008 Overcoming therapeutic resistance in malignant gliomas: current practices and future directions Cancer Treat Res 139 173 189 1:CAS:528:DC%2BD1MXhtVGmsbs%3D 18236717
2. WP Mason 2008 Emerging drugs for malignant glioma Expert Opin Emerg Drugs 13 1 81 94 10.1517/14728214.13.1.81 1:CAS:528:DC%2BD1cXislKnurc%3D 18321150 2008AIPC.1049...81M (Pubitemid 351448704)
3. AJ Sawyer JM Piepmeier WM Saltzman 2006 New methods for direct delivery of chemotherapy for treating brain tumors Yale J Biol Med 79 3-4 141 152 1:CAS:528:DC%2BD1cXisFKgtr0%3D 17940624
4. C Guerin A Olivi JD Weingart HC Lawson H Brem 2004 Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers Invest New Drugs 22 1 27 37 10.1023/B:DRUG.0000006172.65135.3e 1:CAS:528: DC%2BD3sXptlyrtr8%3D 14707492 (Pubitemid 38196980)
5. HC Lawson P Sampath E Bohan MC Park N Hussain A Olivi J Weingart L Kleinberg H Brem 2007 Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience J Neurooncol 83 1 61 70 10.1007/s11060-006-9303-1 1:CAS:528:DC%2BD2sXmtVCqs7o%3D 17171441 (Pubitemid 46647166)
6. MS Lesniak U Upadhyay R Goodwin B Tyler H Brem 2005 Local delivery of doxorubicin for the treatment of malignant brain tumors in rats Anticancer Res 25 6B 3825 3831 1:CAS:528:DC%2BD2MXht12itrnI 16312042 (Pubitemid 41665151)
7. CO Noble MT Krauze DC Drummond Y Yamashita R Saito MS Berger DB Kirpotin KS Bankiewicz JW Park 2006 Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy Cancer Res 66 5 2801 2806 10.1158/0008-5472.CAN-05-3535 1:CAS:528: DC%2BD28XhvV2gt78%3D 16510602
8. SH Lin LR Kleinberg 2008 Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies Expert Rev Anticancer Ther 8 3 343 359 10.1586/14737140.8.3.343 1:CAS:528:DC%2BD1cXjvF2lur0%3D 18366283 (Pubitemid 351836283)
9. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jaaskelainen Z Ram 2003 A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro Oncol 5 2 79 88 10.1215/15228517-5-2-79 1:CAS:528:DC%2BD3sXjtVKltL4%3D 12672279 (Pubitemid 36422560)
10. M Westphal Z Ram V Riddle D Hilt E Bortey 2006 Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochir (Wien) 148 3 269 275 10.1007/s00701-005-0707-z 1:STN:280:DC%2BD28znvFWmtQ%3D%3D discussion 275 (Pubitemid 43341024)
11. Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess. 2007;11(45):iii-iv, ix-221.
12. AM Omuro JY Delattre 2007 Editorial: what is new in the treatment of gliomas? Curr Opin Neurol 20 6 704 707 10.1097/WCO.0b013e3282f1beef 17992093 (Pubitemid 350085014)
13. KL von Eckardstein R Reszka JC Kiwit 2005 Intracavitary chemotherapy (paclitaxel/carboplatin liquid crystalline cubic phases) for recurrent glioblastoma-clinical observations J Neurooncol 74 3 305 309 10.1007/s11060-004-7559-x (Pubitemid 41444499)
14. MR Gilbert JG Supko T Batchelor G Lesser JD Fisher S Piantadosi S Grossman 2003 Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma Clin Cancer Res 9 8 2940 2949 1:CAS:528:DC%2BD3sXmtF2iu7Y%3D 12912940 (Pubitemid 37006309)
15. P Hau K Fabel U Baumgart P Rummele O Grauer A Bock C Dietmaier W Dietmaier J Dietrich C Dudel, et al. 2004 Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma Cancer 100 6 1199 1207 10.1002/cncr.20073 1:CAS:528:DC%2BD2cXivFagtr4%3D 15022287 (Pubitemid 38325948)
16. MD Prados WK Yung KA Jaeckle HI Robins MP Mehta HA Fine PY Wen TF Cloughesy SM Chang MK Nicholas, et al. 2004 Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study Neuro Oncol 6 1 44 54 10.1215/S1152851703000292 1:CAS:528:DC%2BD2cXht1aqsr8%3D 14769140 (Pubitemid 38139639)
17. JP Fruehauf H Brem S Brem A Sloan G Barger W Huang R Parker 2006 In vitro drug response and molecular markers associated with drug resistance in malignant gliomas Clin Cancer Res 12 15 4523 4532 10.1158/1078-0432.CCR-05-1830 1:CAS:528:DC%2BD28XnvVGksr8%3D 16899598 (Pubitemid 44297801)
18. JE Wolff T Trilling G Molenkamp RM Egeler H Jurgens 1999 Chemosensitivity of glioma cells in vitro: a meta analysis J Cancer Res Clin Oncol 125 8-9 481 486 10.1007/s004320050305 1:CAS:528:DyaK1MXlsF2nsbw%3D 10480340 (Pubitemid 29410412)
19. PB Storm JL Moriarity B Tyler PC Burger H Brem J Weingart 2002 Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy J Neurooncol 56 3 209 217 10.1023/A:1015003232713 12061726 (Pubitemid 34476989)
20. PB Storm VM Renard JL Moriarity B Tyler RE Wilentz H Brem JD Weingart 2004 Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma Cancer Chemother Pharmacol 54 4 361 367 10.1007/s00280-004-0800-7 1:CAS:528:DC%2BD2cXntV2htrY%3D 15197484 (Pubitemid 39304431)
21. JD Weingart RC Thompson B Tyler OM Colvin H Brem 1995 Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model Int J Cancer 62 5 605 609 10.1002/ijc. 2910620519 1:CAS:528:DyaK2MXoslSksro%3D 7665233
22. AL Lewis MV Gonzalez AW Lloyd B Hall Y Tang SL Willis SW Leppard LC Wolfenden RR Palmer PW Stratford 2006 DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization J Vasc Interv Radiol 17 2 Pt 1 335 342 10.1097/01.RVI.0000195323.46152.B3 16517780 (Pubitemid 44341453)
23. MV Gonzalez Y Tang GJ Phillips AW Lloyd B Hall PW Stratford AL Lewis 2008 Doxorubicin eluting beads-2: Methods for evaluating drug elution and in vitro: in vivo correlation J Mater Sci Mater Med 19 2 767 775 10.1007/s10856-006-0040-y 1:CAS:528:DC%2BD1cXhs1Wrt70%3D 17653626 (Pubitemid 351244006)
24. AL Lewis MV Gonzalez SW Leppard JE Brown PW Stratford GJ Phillips AW Lloyd 2007 Doxorubicin eluting beads -1: effects of drug loading on bead characteristics and drug distribution J Mater Sci Mater Med 18 9 1691 1699 10.1007/s10856-007-3068-8 1:CAS:528:DC%2BD2sXos1Cgu7o%3D 17483878 (Pubitemid 47224923)
25. RR Taylor Y Tang MV Gonzalez PW Stratford AL Lewis 2007 Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties Eur J Pharm Sci 30 1 7 14 10.1016/j.ejps.2006.09.002 1:CAS:528:DC%2BD28XhtlalsbnP 17030118 (Pubitemid 44908921)
26. AL Lewis RR Taylor B Hall MV Gonzalez SL Willis PW Stratford 2006 Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol 17 8 1335 1343 10.1097/01.RVI.0000228416.21560.7F 16923981 (Pubitemid 44259017)
27. J Namur M Wassef J-M Millot AL Lewis M Manfait A Laurent 2010 Doxorubicin eluting beads for liver embolization: pathological findings and correlation with drug distribution in the tissue J Vasc Interv Radiol 21 259 267 10.1016/j.jvir.2009.10.026 20123210
28. H Druckrey C Landschutz S Ivankovic 1970 Transplacental induction of malignant tumours of the nervous system. II. Ethyl-nitrosurea in 10 genetically defined strains of rats Z Krebsforsch 73 4 371 386 10.1007/BF00524174 1:STN:280:DyaE3c7nvVehsQ%3D%3D 4315198
29. H Druckrey B Schagen S Ivankovic 1970 Induction of neurogenic malignancies by one single dose of ethyl-nitrosourea (ENU) given to newborn and juvenile BD IX-strain rats Z Krebsforsch 74 2 141 161 10.1007/BF00525880 1:CAS:528:DyaE3cXks1Churs%3D 4326539
30. T Ozawa J Wang LJ Hu AW Bollen KR Lamborn DF Deen 2002 Growth of human glioblastomas as xenografts in the brains of athymic rats In Vivo 16 1 55 60 11980362 (Pubitemid 34436176)
31. W Yang RF Barth G Wu MJ Ciesielski RA Fenstermaker BA Moffat BD Ross CJ Wikstrand 2005 Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4 Clin Cancer Res 11 1 341 350 1:CAS:528:DC%2BD2MXhtVegt7c%3D 15671565 (Pubitemid 40075814)
32. E Fournier C Passirani A Vonarbourg L Lemaire N Colin S Sagodira P Menei JP Benoit 2003 Therapeutic efficacy study of novel 5-FU-loaded PMM 2.1.2-based microspheres on C6 glioma Int J Pharm 268 1-2 31 35 10.1016/j.ijpharm.2003.08. 014 1:CAS:528:DC%2BD3sXptFGqs7g%3D 14643974 (Pubitemid 37487820)
33. G Fiorentini C Aliberti G Turrisi A Del Conte S Rossi G Benea P Giovanis 2007 Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study In Vivo 21 6 1085 1091 1:CAS:528:DC%2BD1cXkvVantQ%3D%3D 18210761 (Pubitemid 350286341)
34. K Malagari K Chatzimichael E Alexopoulou A Kelekis B Hall S Dourakis S Delis A Gouliamos D Kelekis 2008 Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients Cardiovasc Intervent Radiol 31 2 269 280 10.1007/s00270-007-9226-z 17999110
35. P Menei M Boisdron-Celle A Croue G Guy JP Benoit 1996 Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats Neurosurgery 39 1 117 123 10.1097/00006123-199607000-00023 1:STN:280:DyaK28zpvVejug%3D%3D 8805147 discussion 123-4 (Pubitemid 26230465)
36. RJ Tamargo JI Epstein CS Reinhard M Chasin H Brem 1989 Brain biocompatibility of a biodegradable, controlled-release polymer in rats J Biomed Mater Res 23 2 253 266 10.1002/jbm.820230209 1:CAS:528:DyaL1MXht1Whu7w%3D 2708412 (Pubitemid 19042070)
37. Y Yamashita MT Krauze T Kawaguchi CO Noble DC Drummond JW Park KS Bankiewicz 2007 Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts Neuro Oncol 9 1 20 28 10.1215/15228517-2006-016 1:CAS:528:DC%2BD2sXht1Ojs74%3D 17018695 (Pubitemid 46543485)
38. MT Krauze CO Noble T Kawaguchi D Drummond DB Kirpotin Y Yamashita E Kullberg J Forsayeth JW Park KS Bankiewicz 2007 Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts Neuro Oncol 9 4 393 403 10.1215/15228517-2007-019 1:CAS:528:DC%2BD2sXht1GksLjP 17652269
39. V Pavillard D Kherfellah S Richard J Robert D Montaudon 2001 Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants Br J Cancer 85 7 1077 1083 10.1054/bjoc.2001.2027 1:CAS:528:DC%2BD3MXot1Skuro%3D 11592782 (Pubitemid 33016012)
40. E Eyol A Boleij RR Taylor AL Lewis MR Berger 2008 Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin Clin Exp Metastasis 25 3 273 282 10.1007/s10585-008-9142-x 1:CAS:528:DC%2BD1cXnt1ensbg%3D 18259882
41. Y Yang JS Jiang B Du ZF Gan M Qian P Zhang 2009 Preparation and properties of a novel drug delivery system with both magnetic and biomolecular targeting J Mater Sci Mater Med 20 1 301 307 10.1007/s10856-008-3577-0 1:CAS:528:DC%2BD1MXlvFGktg%3D%3D 18791664
42. E Fournier C Passirani C Montero-Menei N Colin P Breton S Sagodira P Menei JP Benoit 2003 Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats Cancer 97 11 2822 2829 10.1002/cncr.11388 1:CAS:528:DC%2BD3sXkslWrsL0%3D 12767096 (Pubitemid 36605151)
43. L Lemaire VG Roullin F Franconi MC Venier-Julienne P Menei P Jallet JJ Le Jeune JP Benoit 2001 Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study NMR Biomed 14 6 360 366 10.1002/nbm.720 1:CAS:528:DC%2BD3MXot1Ghtr4%3D 11599034 (Pubitemid 32982700)
44. VG Roullin M Mege L Lemaire JP Cueyssac MC Venier-Julienne P Menei E Gamelin JP Benoit 2004 Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization Pharm Res 21 9 1558 1563 10.1023/B:PHAM.0000041448.22771.48 1:CAS:528:DC%2BD2cXnsFyjsb4%3D 15497679 (Pubitemid 41184384)
45. P Menei L Capelle J Guyotat S Fuentes R Assaker B Bataille P Francois D Dorwling-Carter P Paquis L Bauchet, et al. 2005 Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial Neurosurgery 56 2 242 248 10.1227/01.NEU.0000144982.82068.A2 15670372 (discussion 242-8) (Pubitemid 40204942)
46. P Menei E Jadaud N Faisant M Boisdron-Celle S Michalak D Fournier M Delhaye JP Benoit 2004 Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma Cancer 100 2 405 410 10.1002/cncr.11922 1:CAS:528:DC%2BD2cXhtVOgsrk%3D 14716778 (Pubitemid 38063652)